By targeting GIP, GLP-1, and glucagon receptors, the investigational triple agonist could mark the next evolution in incretin ...

Amylin-based petrelintide has achieved good results at Phase II for obesity, showing 8-11% weight loss and a good side effect profile.

Just a small amount of recorded speech could identify type 2 diabetes using an AI-based screening tool, research presented at a scientific conference suggests.

Kodiak's eye drug Zenkuda edges towards approval after another successful Phase III trial in wet AMD adds to other successful ...

Researchers developed ChromAgeNet, an AI tool that detects age-related chromatin changes in blood stem cells from 3D ...

Early treatment is key, as heart and kidney problems increase significantly with time for people with type 2 diabetes.

Reducing reliance on ultracold storage could lower costs, limit vaccine waste, and expand access to mRNA vaccines and other ...

Researchers could simulate hypoxic damage and neuropsychiatric diseases in difficult-to-study human cells and circuits.

Experts debate the evidence, uncertainties, and readiness for widespread use of GRAIL’s Galleri multicancer early detection ...

An existing anti-seizure medication may offer a way to fight diffuse midline glioma, one of the deadliest forms of childhood ...

First-in-human treatment preparation and infrastructure provide hints for health systems to safely deliver thousands of ...

Reduced bone density in the spine has been linked with poorer brain function, in research that could be particularly ...